% | $
Quotes you view appear here for quick access.

công ty Questcor Pharmaceuticals Message Board

  • maxdad01 maxdad01 Mar 12, 2013 12:18 PM Flag

    From November 2nd, 2012...Just an example of the shortcraap we've seen for months!!!

    Thought you guys would enjoy seeing a prior attack example...Note that Orphan DESIGNATION = ORPHAN APPLICATION (cost of this a few hundred bucks :-)...AND Cerium Pharmaceuticals HQ located in a house in Maryland...what a joke!!!

    mistaken report caused shares of Questcor Pharmaceuticals (NASDAQ:QCOR) to take a dive on Friday, saying that Cerium Pharmaceuticals had been granted an FDA orphan drug designation for Synacthen Depot, which is a synthetic equivalent of Acthar. The headline in error stated that the FDA had okayed a synthetic version of Acthar, rather than the Orphan Drug Designation it had actually been given, says a Seeking Alpha contributor. The headline has since been pulled and refiled to reflect the correction, but the damage to the shares stuck.
    NOTE: BUT NOT FOR LONG LOL !!! But this event does speak directly to the persistent misrepresentations that are thrown at Questcor...STICK WITH THE ANALYSTS, ESPECIALLY THOSE WHO HAVE RECENTLY MET WITH QUESTCOR MANAGEMENT !!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies